STaR-CABG: Multi- Level and Integrated Analysis of Mechanisms Underlying Atrial Dysfunction

Sponsor
National Heart Centre Singapore (Other)
Overall Status
Unknown status
CT.gov ID
NCT02789943
Collaborator
Duke-NUS Graduate Medical School (Other)
750
1
95
7.9

Study Details

Study Description

Brief Summary

Integrated and cross-disciplinary analysis of human physiology and disease provides unbiased and deeply informative insights into human health and disease. In this study the investigators will recruit patients undergoing coronary artery bypass surgery to study the atrium of the heart or the aortic wall that when diseased can cause strokes.

Hypothesis: Systems-level analysis of the left atrium and aorta cells that integrates imaging, histological, cellular and molecular data will identify new mechanism for cardiovascular form and function.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cardiac Bypass Surgery

Detailed Description

While there are many sub-aims to this study, the overarching goal is to define molecular mechanisms underlying atrial dysfunction. Here the investigator provide a power calculation based on detecting the genetic control points of gene expression (eQTLs) in the human atrial fibroblast. The investigator and many others have shown that tissue-specific eQTLs can be robustly identified at genome-wide significance in segregating populations of ~200. In this study the investigator propose eQTL association analysis in humans, which have previously been successfully performed in cohorts of less than 1000 subjects. The general applicability of this approach has been validated in multiple studies across multiple tissues in cohorts of between 200-1000 subjects.Based on published imaging genetic studies that have been successfully applied in small cohorts (<500) and the success of echo-based, semi-quantitative studies of ventricular dimensions, the investigator are confident that our quantitative studies of 750 individuals are powered to detect genome wide significant loci for the traits under study.

Despite intensive research there is a critical gap in our knowledge in the mechanisms underlying atrial fibrillation, which is a major cause of stroke and heart failure and increasingly common as it is a disease of the elderly. This project will address this important gap in our knowledge and provide new insights into disease pathogenesis with the goal of stratifying participants to prevent strokes and for treating the underlying substrate.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
750 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The National Heart Centre Singapore Prospective CABG Cohort: Multi- Level and Integrated Analysis of Mechanisms Underlying Atrial Dysfunction
Study Start Date :
May 1, 2013
Anticipated Primary Completion Date :
Jul 1, 2017
Anticipated Study Completion Date :
Apr 1, 2021

Outcome Measures

Primary Outcome Measures

  1. First occurrence of cardiovascular event [One year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing elective cardiac bypass surgery during which a sample of right atrial appendage and/or aortic button can be removed.
Exclusion Criteria:
  • Infection within 2 weeks preceding the operation or immunosuppressive therapy.

  • Patients not able or willing to consent for study.

  • Previous atrial intervention.

  • Patients who cannot be followed up.

  • Exclude patients with significant valvular disease (any planned valvular surgery, MR > severe, AS > severe, TR > severe).

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Heart Centre Singapore Singapore

Sponsors and Collaborators

  • National Heart Centre Singapore
  • Duke-NUS Graduate Medical School

Investigators

  • Principal Investigator: Stuart Alexander Cook, National Heart Centre Singapore / Duke NUS Graduate Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
National Heart Centre Singapore
ClinicalTrials.gov Identifier:
NCT02789943
Other Study ID Numbers:
  • 2013/103/C
First Posted:
Jun 3, 2016
Last Update Posted:
Apr 6, 2017
Last Verified:
May 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by National Heart Centre Singapore
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2017